UltraClear®
The world's first cold fiber laser
A 2910 nm cold fiber laser for aesthetic practices. FDA cleared and launched in the United States in 2022, UltraClear's cold ablative approach is designed to resurface skin while limiting residual heat.
Why practices choose UltraClear
Claims as published by UltraClear. Full indications, clinical data and safety information are on ultraclearlaser.com.
Skin types
Safe for all skin types and all ages
A cold ablative approach designed to limit residual heat so providers can treat a broad range of skin types.
Experience
Less downtime
Published as little-to-no downtime for many treatments, so patients return to their day sooner.
Range
Ultimate versatility
One platform for a wide range of treatments, with technologies including 3DMIRACL®, 3DIntelliPulse® and Laser-Coring™.
From Acclaro
Engineered by the company behind it
UltraClear is the first platform built on Acclaro Medical's cold fiber technology. The team that developed it continues to support providers through physician education, clinical research and ongoing training.
Clinical publications, webinars and provider resources live on the UltraClear site. Acclaro's own resources for partners and distributors are collected under Resources on this site.
Ready to learn more?
Clinical results, provider stories, training and the practice calculator are all on the UltraClear site.